Align Technology, Inc.
NASDAQ Global SelectCapital Structure
•
in mil. unless spec.Working Capital
•
in mil. unless spec.Growth Rates
•
in mil. unless spec.Quarterly Revenue
•
in mil. unless spec.Quarterly Earnings Per Share
•
in mil. unless spec.Quarterly Dividends Per Share
•
in mil. unless spec.Company Description
- CEO
- Joseph Hogan
- Full Time Employees
- 20,435
- Sector
- Healthcare
- Industry
- Medical - Devices
- Address
- 410 North Scottsdale Road Tempe AZ United States of America 85288
- IPO Date
- Jan 30, 2001
- CIK
- 0001097149
- Website
- aligntech.com
- Similar Companies
- Business
- Align Technology, Inc. (Nasdaq: ALGN) manufactures and markets a comprehensive portfolio of clear aligner systems, intraoral scanners, and digital dentistry solutions for orthodontic and restorative treatments worldwide. The company offers the Invisalign System, including Invisalign Comprehensive, Teen, First, Go, and Moderate packages with proprietary SmartTrack material, SmartForce features, and ClinCheck treatment planning software; Vivera retainers; the iTero family of intraoral scanners such as iTero Element Plus Series, Element 5D, and Element 2 with advanced imaging, TimeLapse technology, and integration for restorative workflows; the Align Digital Platform encompassing Exocad CAD/CAM software for dental labs and practices; and the Invisalign Palatal Expander System, a direct 3D-printed orthodontic device for maxillary expansion in growing patients. Founded in 1997 and headquartered in Tempe, Arizona, with manufacturing in Mexico, Israel, and China, treatment planning in Costa Rica, and operations across more than 100 markets including the U.S., EMEA, Asia Pacific, and Latin America, Align serves orthodontists, general dentists, and over 271,000 trained doctors treating approximately 20 million patients to date. In January 2024, Align acquired Cubicure GmbH for approximately €79 million to enhance direct 3D printing capabilities for scalable production of custom appliances like the Invisalign Palatal Expander, which launched commercially in select markets including Canada, Australia, and EMEA in 2024-2025 pending regulatory approvals; the company continues expanding the Invisalign portfolio with innovations in teen and pediatric treatments while reporting Q3 2025 revenues of $995.7 million.
Company News
Quentin Blackford to Join Align Technology Board of Directors
26,510 Shares in Align Technology, Inc. $ALGN Acquired by Canada Pension Plan Investment Board
Why Is Align Technology (ALGN) Down 8.4% Since Last Earnings Report?
Align Technology Inc (ALGN) Stock Down 5.6% -- Now Undervalued? GF Score: 89/100
How the U.K. VAT Ruling Could Reshape Align's 2026 Earnings Outlook
Should Investors Buy Align as Growth Meets Valuation and Demand Risks?
Align Technology Prevails in China Patent Infringement Action Against Angelalign
Align Technology Prevails in China Patent Infringement Action Against Angelalign
Contravisory Investment Management Inc. Makes New $1.11 Million Investment in Align Technology, Inc. $ALGN
Align Technology, Inc. $ALGN Shares Sold by Assenagon Asset Management S.A.
Align Technology: A Structurally Better Business Trading At A Structurally Lower Multiple
Align Technology Inc (ALGN) Stock Down 3.2% -- Now Undervalued? GF Score: 89/100
California State Teachers Retirement System Has $13.59 Million Stock Holdings in Align Technology, Inc. $ALGN
Align Technology: Attractively Valued But Growth Still Needs To Pick Up
First Trust Advisors LP Sells 57,392 Shares of Align Technology, Inc. $ALGN
ALGN Stock Up Post Q2 Earnings and Revenue Beat, Margins Rise
ALGN Q2 Earnings Call Highlights Digital Growth Push
Align Technology Inc (ALGN) (Q2 2026) Earnings Call Highlights: Record Revenue and Clear Aligner Volume Amidst Market Headwinds
Align Technology, Inc. (ALGN) Q2 2026 Earnings Call Transcript
Align Technology (ALGN) Reports Q2 Earnings: What Key Metrics Have to Say